BioPharmX Corporation (BPMX): Price and Financial Metrics
BPMX Price/Volume Stats
| Current price | $6.12 | 52-week high | $6.30 |
| Prev. close | $0.56 | 52-week low | $0.25 |
| Day low | $5.47 | Volume | 336,508 |
| Day high | $6.30 | Avg. volume | 2,150,348 |
| 50-day MA | $0.34 | Dividend yield | N/A |
| 200-day MA | $0.37 | Market Cap | 111.86M |
BPMX Stock Price Chart Interactive Chart >
Latest BPMX News From Around the Web
Below are the latest news stories about BioPharmX Corp that investors may wish to consider to help them evaluate BPMX as an investment opportunity.
BioPharmX Announces 1-for-12 Reverse Stock Split Merger Transaction Expected to Close on May 18, 2020BioPharmX Corporation (NYSE American: BPMX) ("BioPharmX" or the "Company"), a specialty pharmaceutical company focused on developing innovative medical dermatology products, today announced that, in anticipation of closing its merger with Timber Pharmaceuticals, it will effect a 1-for-12 reverse stock split of its outstanding common stock. The reverse stock split is expected to be effective for trading purposes as of the commencement of trading on Tuesday, May 19, 2020. |
The Daily Biotech Pulse: ASCO Abstracts Create Stock Ripples, Applied DNA's Coronavirus Test Receives EUA, Biopharmx Shareholders Vet Reverse MergerHere's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs May 13.) … |
BioPharmX Corporation Announces Approval of Merger by Stockholders at Special MeetingCAMPBELL, Calif., May 13, 2020 /PRNewswire/ -- BioPharmX Corporation (NYSE American: BPMX) ("BioPharmX") today announced that all proposals related to its proposed merger with Timber Pharmaceuticals LLC ("Timber") were approved by BioPharmX's stockholders at a special meeting held on May… |
BioPharmX Corporation Urges Stockholders to Vote Now on Proposed Merger with Timber PharmaceuticalsCAMPBELL, Calif., May 8, 2020 /PRNewswire/ -- BioPharmX Corporation (NYSE American: BPMX) ("BioPharmX") is urging its stockholders to vote now on the proposed merger of BioPharmX with Timber Pharmaceuticals LLC ("Timber") and related matters as described in the proxy statement/prospectus…. |
BioPharmX And Timber Pharmaceuticals Announce Entry into Merger AgreementSAN JOSE, Calif. and WOODCLIFF LAKE, N.J., Jan. 28, 2020 /PRNewswire/ --BioPharmX Corporation (NYSE American: BPMX) ("BioPharmX") and Timber Pharmaceuticals LLC ("Timber"), a privately held biopharmaceutical company focused on the development and commercialization of treatments for orphan… |
BPMX Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | -69.28% |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | 0.00% |
| 2019 | -84.58% |
Continue Researching BPMX
Want to see what other sources are saying about BioPharmX Corp's financials and stock price? Try the links below:BioPharmX Corp (BPMX) Stock Price | Nasdaq
BioPharmX Corp (BPMX) Stock Quote, History and News - Yahoo Finance
BioPharmX Corp (BPMX) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...